SCHEMBL6237573

SCHEMBL6237573

CCc1cn([C@H]2C[C@H](OC(=O)c3ccc(Cl)cc3)[C@@H](COC(=O)c3ccc(Cl)cc3)O2)c(=O)[nH]c1=O

nearest known ligand 0.55

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RNASE1 P07998 1/20 0.55
UPP1 Q16831 1/20 0.53
TK2 O00142 1/20 0.43
TK1 P04183 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7071383 1.00 RNASE1 (0.55) RNASE1UPP1TK2TK1
SCHEMBL5710067 0.90 RNASE1 (0.68) RNASE1UPP1TK2TK1
SCHEMBL20833584 0.88 UPP1 (0.54) RNASE1UPP1TK2TK1
SCHEMBL9811657 0.87 UPP1 (0.52) RNASE1UPP1
SCHEMBL9228356 0.86 LMNA (0.52) RNASE1UPP1TK2
SCHEMBL9228359 0.86 LMNA (0.52) RNASE1UPP1TK2
SCHEMBL6926181 0.84 TK1 (0.53) RNASE1UPP1TK2TK1
SCHEMBL6235590 0.84 TK1 (0.53) RNASE1UPP1TK2TK1
SCHEMBL5709922 0.84 UPP1 (0.57) RNASE1UPP1
SCHEMBL30698170 0.81 RNASE1 (0.61) RNASE1UPP1TK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363928-B1 PROCESS FOR THE PREPARATION OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE MENARINI RICERCHE SPA (IT) 2005-05-04 EP disclosed
US-6864366-B2 Process for the preparation of (e)-5-(2-bromovinyl)-2′-deoxyuridine MENARINI RICHERCHE S.P.A. (IT) 2005-03-08 US disclosed
US-20040077586-A1 Process for the preparation of (e)-5-(2-bromovinyl)-2'-deoxyuridine MENARINI RICERCHE S.P.A. (IT) 2004-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077586-A1 Process for the preparation of (e)-5-(2-bromovinyl)-2'-deoxyuridine DUT, DUS2, DPYD RNASE1 1417/4885UPP1 41/4885TK2 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.